Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Delatour

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Carcinogenesis|February 1, 1996
Observation and prevention of an artefactual formation of oxidized DNA bases and nucleosides in the GC-EIMS methodT Douki, T Delatour, F Bianchini, et al.
Chemical Research in Toxicology|October 1, 1996
Measurement of oxidative damage at pyrimidine bases in gamma-irradiated DNAT Douki, T Delatour, F Paganon, et al.
Journal of Toxicology|July 22, 2011
Evidence for a role of oxidative stress in the carcinogenicity of ochratoxin aM Marin-Kuan, V Ehrlich, T Delatour, et al.
Chemical Research in Toxicology|October 7, 1998
A novel vicinal lesion obtained from the oxidative photosensitization of TpdG: characterization and mechanistic aspectsT Delatour, T Douki, D Gasparutto, et al.
Amino Acids|September 30, 2005
Synthesis, tandem MS- and NMR-based characterization, and quantification of the carbon 13-labeled advanced glycation endproduct, 6-N-carboxymethyllysineT Delatour, F Fenaille, V Parisod, et al.
Mutation Research|March 5, 1999
Hydroxyl radicals and DNA base damageJ Cadet, T Delatour, T Douki, et al.
Toxicology and Applied Pharmacology|July 27, 2007
MAPK-ERK activation in kidney of male rats chronically fed ochratoxin A at a dose causing a significant incidence of renal carcinomaM Marin-Kuan, S Nestler, C Verguet, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|October 28, 2005
A toxicogenomics approach to identify new plausible epigenetic mechanisms of ochratoxin a carcinogenicity in ratM Marin-Kuan, S Nestler, C Verguet, et al.
Toxicology and Applied Pharmacology|March 16, 2010
Identification of nevadensin as an important herb-based constituent inhibiting estragole bioactivation and physiology-based biokinetic modeling of its possible in vivo effectW Alhusainy, A Paini, A Punt, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Carcinogenesis|February 1, 1996
Observation and prevention of an artefactual formation of oxidized DNA bases and nucleosides in the GC-EIMS methodT Douki, T Delatour, F Bianchini, et al.
Chemical Research in Toxicology|October 1, 1996
Measurement of oxidative damage at pyrimidine bases in gamma-irradiated DNAT Douki, T Delatour, F Paganon, et al.
Journal of Toxicology|July 22, 2011
Evidence for a role of oxidative stress in the carcinogenicity of ochratoxin aM Marin-Kuan, V Ehrlich, T Delatour, et al.
Chemical Research in Toxicology|October 7, 1998
A novel vicinal lesion obtained from the oxidative photosensitization of TpdG: characterization and mechanistic aspectsT Delatour, T Douki, D Gasparutto, et al.
Amino Acids|September 30, 2005
Synthesis, tandem MS- and NMR-based characterization, and quantification of the carbon 13-labeled advanced glycation endproduct, 6-N-carboxymethyllysineT Delatour, F Fenaille, V Parisod, et al.
Mutation Research|March 5, 1999
Hydroxyl radicals and DNA base damageJ Cadet, T Delatour, T Douki, et al.
Toxicology and Applied Pharmacology|July 27, 2007
MAPK-ERK activation in kidney of male rats chronically fed ochratoxin A at a dose causing a significant incidence of renal carcinomaM Marin-Kuan, S Nestler, C Verguet, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|October 28, 2005
A toxicogenomics approach to identify new plausible epigenetic mechanisms of ochratoxin a carcinogenicity in ratM Marin-Kuan, S Nestler, C Verguet, et al.
Toxicology and Applied Pharmacology|March 16, 2010
Identification of nevadensin as an important herb-based constituent inhibiting estragole bioactivation and physiology-based biokinetic modeling of its possible in vivo effectW Alhusainy, A Paini, A Punt, et al.
Pageof 1